Abstract CT141: mRNA-4157 (V940) individualized neoantigen therapy (INT) + pembrolizumab (pembro) in advanced unresectable HPV- head & neck carcinoma (HNSCC): Clinical & translational analysis

Authors: Julie E. Bauman, Ricklie A. Julian, Jessica L. Geiger, Janice M. Mehnert, Jeffrey M. Clarke, Manish R. Patel, Martin Gutierrez, Justin F. Gainor, Shyam Srivats, Zhaojie Zhang, Anjali Rao, Vasudha Sehgal, Peijie Hou, Manju Morrissey, Igor Feldman, Lakshmi Srinivasan, Praveen Aanur, Michelle Brown, Robert S. Meehan

Published: 2024-04-05

DOI: 10.1158/1538-7445.am2024-ct141

Source: Full article

Abstract CT141: mRNA-4157 (V940) individualized neoantigen therapy (INT) + pembrolizumab (pembro) in advanced unresectable HPV- head &amp; neck carcinoma (HNSCC): Clinical &amp; translational analysis

Abstract

Abstract CT141: mRNA-4157 (V940) individualized neoantigen therapy (INT) + pembrolizumab (pembro) in advanced unresectable HPV- head & neck carcinoma (HNSCC): Clinical & translational analysis